Working… Menu
Trial record 2 of 3 for:    Rasunoa | stroke

Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime (RASUNOA-Prime)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02533960
Recruitment Status : Recruiting
First Posted : August 27, 2015
Last Update Posted : October 1, 2019
Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma
Boehringer Ingelheim
Bristol-Myers Squibb
Daiichi Sankyo, Inc.
University of Wuerzburg
Information provided by (Responsible Party):
Prof. Roland Veltkamp, University Hospital Heidelberg

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 2020
Estimated Study Completion Date : October 2020